|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 273.25 USD | -2.27% |
|
-3.42% | -6.92% |
| 07-14 | Where would AI lead Pharma in the long run? |  |
| 07-13 | Antengene Receives $60 Million Milestone in UCB Licensing Deal | MT |
Chart: Technical Analysis
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- UCB Stock
- UCBJF Stock
- Charts UCB
Select your edition
All financial news and data tailored to specific country editions
